Acrivon Therapeutics, Inc.
All insider transactions
| Move | Insider | Δ shares | Value | Impact |
|---|---|---|---|---|
| Buy | Devroe Eric Executive | +10,000 | $17.2K | low |
| Buy | Blume-Jensen Peter CEO | +49,000 | $82.1K | medium |
| Buy | Levy Adam D. Executive | +8,832 | $15.0K | low |
| Other | Miller Mary Executive | -659 | $1.3K | low |
| Other | Miller Mary Executive | -217 | $354 | low |
| Other | Peterson Katharine Executive | -116 | $189 | low |
| Other | Gamelin Erick Executive | -471 | $768 | low |
| Other | Devroe Eric Executive | -723 | $1.2K | low |
| Other | Blume-Jensen Peter CEO | -579 | $944 | low |
| Other | Blume-Jensen Peter CEO | -1,302 | $2.1K | low |
| Other | Blume-Jensen Peter CEO | -14,265 | $21.8K | low |
| Other | RA Capital Management, L.P. Director | +3,888,888 | $7.00M | low |
| Other | RA Capital Management, L.P. Director | +9,366 | $0 | low |
| Other | Magovcevic-Liebisch Ivana Director | +9,366 | $0 | low |